Effects of cyclopiazonic acid and thapsigargin on electromechanical activities and intracellular Ca2+ in smooth muscle of carotid artery of hypertensive rats

British Journal of Pharmacology

Volumn 118, Issue 4, 1996, Pages 857-864

  Sekiguchi, F ^a   Shimamura, K ^a   Akashi, M ^a   Sunano, S ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

Carotid artery; Contraction; Cyclopiazonic acid; Intracellular Ca2+; Membrane potential; Smooth muscle; Stroke prone spontaneously hypertensive rat; Thapsigargin

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM CHANNEL; CALCIUM ION; CYCLOPIAZONIC ACID; THAPSIGARGIN; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CAROTID ARTERY; CONTROLLED STUDY; DEPOLARIZATION; ELECTRIC ACTIVITY; ENZYME INHIBITION; HYPERTENSION; MEMBRANE STEADY POTENTIAL; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE TONE; STROKE; VASCULAR SMOOTH MUSCLE;

EID: 0029744805     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15478.x     Document Type: Article

References (42)

1. 2+ mobilization by caffeine in single smooth muscle cells of the rat tail artery. Eur. J. Pharmacol. Mol. Pharmacol. Section, 288, 79-88.
2. i in isolated rat mesenteric artery vascular smooth muscle cells. Pflüger's Arch., 420, 115-117.
3. BIAN, K. & BUKOSKI, R.D. (1995). Myofilament calcium sensitivity of normotensive and hypertensive resistance arteries. Hypertension, 25, 110-116.
4. BOLTON, T.B. (1979). Mechanisms of action of transmitters and other substances on smooth muscle. Physiol. Rev., 59, 606-718.
5. 2+ from SR in vascular smooth muscle cells. Am. J. Physiol., 266, C311-C317.
6. 45Ca influx in mesenteric resistance vessels of the spontaneously hypertensive rat. In 6th international Adalat symposium, ed. Lichtlen, P.R. pp. 225-231, Amsterdam: Excepta Medica.
7. 2+ movement in vascular smooth muscle and their alterations in hypertension. In Membrane Abnormalities in Hypertension, ed. Kwan, C.Y. pp. 145-179. Boca Raton, Florida: CRC Press.
8. CHEUNG, D.W. (1989). Electrophysiological properties of vascular smooth muscle in hypertension. In Membrane Abnormalities in Hypertension, ed. Kwan, C.Y. pp. 1-14. Boca Raton, Florida: CRC Press.
9. CHIESI, M., WRZOSEK, A. & GRUENINGER, S. (1994). The role of the sarcoplasmic reticulum in various types of cardiomyocytes. Molec. Cellular Biochem., 130, 159-171.
10. FUJII K., OHMORI, S., TOMINAGA, S., ABE, I., TAKATA, Y., OHYA, Y., KOBAYASHI, K. & FUJISHIMA, M. (1993). Age-related change in endothelium-dependent hyperpolarization in the rat mesenteric artery. Am. J. Physiol., 265, H509-H516.
11. 3-sensitive Ca-store in activation of Ca-dependent potassium conductance of ileal smooth muscle cells. Gen. Physiol. Biophys., 12, 199-211.
12. GERICKE, M., DROGGMANS, G. & NILIUS, B. (1993). Thapsigargin discharges intracellular calcium stores and induces transmembrane currents in human endothelial cells. Pflügers Arch., 422, 552-557.
13. GOEGER, D.E. & RILEY, R.T. (1989). Interaction of cyclopiazonic acid with rat skeletal muscle sarcoplasmic reticulum vesicles. Biochem. Pharmacol., 38, 3995-4003.
14. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem., 260, 3440-3450.
15. 2+ depletes sarcoplasmic reticulum in intact cardiac myocytes. Am. J. Physiol., 265, H517-H522.
16. KWAN, C.Y. (1985). Dysfunction of calcium handling by smooth muscle in hypertension. Can. J. Physiol. Pharmacol., 63, 366-374.
17. KWAN, C.Y., CHAUDHARY, R., ZHENG, X.-F., NI. J. & LEE, R.M.K.W. (1994). Effects of sarcoplasmic reticulum calcium pump inhibitors on vascular smooth muscle. Hypertension, 23 (Suppl. I), I-156-I-160.
18. LEWARTOWSKI, B., ROZYCKA, M. & JANIAK, R. (1994). Effects of thapsigargin in normal and pretreated with ryanodine guinea pig cardiomyocytes. Am. J. Physiol., 266, H1829-H1839.
19. LOW, A.M., DARBY, P.J., KWAN, C.-Y. & DANIEL, E.E. (1993). Effects of thapsigargin and ryanodine on vascular contractility: cross-talk between sarcoplasmic reticulum and plasmalemma. Eur. J. Pharmacol., 230, 53-62.
20. 2+ pool in vascular smooth muscles. J. Pharmacol Exp. Ther., 258, 1105-1113.
21. 2+ stores in canine mesenteric artery with different refilling mechanisms. Am. J. Physiol., 262, H31-H37.
22. ++ -pump ATPase inhibit relaxation by nitroglycerin and atrial natriuretic factor of the rabbit aorta contracted by phenylephrine. J. Pharmacol. Exp. Ther., 265, 1187-1192.
23. MACARTHUR, H., HECKER, M., BUSSE, R. & VANE, L.R. (1993). Selective inhibition of agonist-induced but not shear stress-dependent release of endothelial autacoids by thapsigargin. Br. J. Pharmacol., 108, 100-105.
24. 2+ -ATPase inhibitor, cyclopiazonic acid, on electromechanical coupling in the guinea-pig ureter. Br. J. Pharmacol., 114, 127-137.
25. 2+ permeability of the plasma membrane. J. Biol. Chem., 266, 20856-20862.
26. MIKKELSEN, E.O., THASTRUP, O. & CHRISTENSEN. S.B. (1988). Effects of thapsigargin isolated rat thoracic aorta. Pharmacol. Toxicol., 62, 7-11.
27. 2+ permeability of endoplasmic reticulum. Eur. J. Pharmacol. -Mol. Pharmacol. Section, 227, 391-394.
28. 2+ -ATPase inhibitor, cyclopiazonic acid, possibly through nitric oxide formation. Br. J. Pharmacol., 111, 655-662.
29. NAGANOBU, K., TAKAGI, M., KAWASAKI. H. & ITO, K. (1994). Modification by cyclopiazonic acid and ryanodine of depolarization-induced contraction in rat mesenteric artery. Eur. J. Pharmacol., 251, 307-310.
30. 2+ distribution in vascular smooth muscle cells of spontaneously hypertensive rats, J. Vasc. Res., 30, 116-120.
31. 2+ ]. J. Smooth Muscle Res., 29, 69-79.
32. 2+ -ATPase of sarcoplasmic reticulum. J Biol. Chem., 264, 17816-17823.
33. 2+ signaling in A7r5 cultured vascular smooth muscle cells. Am. Soc. Phamacol. Exp. Ther., 40, 1006-1013.
34. + currents in guinea-pig smooth muscle cells. Br. J. Pharmacal., 107, 134-140.
35. TAKEMURA, H., HUGHES. A.R., THASTRUP, O. & PUTNEY, JR J.W. (1989). Activation of calcium by the tumor promoter thapsigargin in a parotid acinar cells. J. Biol. Chem., 264, 12266-12271.
36. 2+ in aortic smooth muscle from spontaneously hypertensive and normotensive rats. Clin. Exp. Hypertension, 16, 493-506.
37. 2+ -ATPase. Proc. Natl. Acad. Sci. U.S.A., 87, 2466-2470.
38. 2+ -ATPase inhibitor, on contraction responses in skinned ileal smooth muscle. Br. J. Pharmacol., 106, 208-214.
39. 2+ -ATPase in sarcoplasmic reticulum, increases excitability in ileal smooth muscle. Br. J. Pharmacol., 110, 565-572.
40. 2+ entry in vascular smooth muscle cells: nicardipine-sensitive and -insensitive pathways. Am. J. Physiol., 262, C1258-C1265.
41. 2+ -ATPase, on the frequency-dependence of the contraction-relaxation cycle of the guinea-pig isolated atrium. Br. J. Pharmacol., 11, 1001-1007.
42. 2+ influx through nonspecific cation channels in endothelial cells. Eur. J. Pharmacol., 251, 119-125.